HEALTH● LOWJul 31 · Jul 31, 2026, 2:45 PM
Handa Oncology Receives FDA Tentative Approval for OMCAZIO ( cabozantinib ) Capsules
tennesseedaily.com · United States
Handa Oncology has received tentative FDA approval for its OMCAZIO (cabozantinib) capsules. This marks a significant regulatory milestone for a new oncology treatment.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
See it on the live mapUnited States and nearby eventsMore from United StatesLatest stories and threat level
More from United States
POLITICS2h agoIranian president blames United States for failure of interim peace dealAfricanews [en]WORLD14h agoF1 United States GP: race schedule, how and where to watch Formula 1ClarínPOLITICS17h agoCountdown to the United States elections: Donald Trump and Melania voted earlyClarínPOLITICS20h agoALÇUFROM : What the United States gets wrong about France student protests - The Cavalier Daily - University of Virginia Student Newspapercavalierdaily.com · United States
More in Health
HEALTH21m agoWhat benefits did consuming more than 30 plant-based foods during the week have for my body?BBC AfriqueHEALTH22m agoTrained 108 ambulance EMTs to provide first aid for eye traumaThe HinduHEALTH43m agoHyderabad’s Osmania General Hospital strengthens gender-affirming surgical care for transgender peopleThe HinduHEALTHBREAKING1h agoJUST IN: Ebola: Nigeria identifies 53 contacts linked to confirmed casePremium Times